EU–Japan › Pharmaceutical products
EU–Japan trade in pharmaceutical products
In May 2026, the EU exported €717M of pharmaceutical products to Japan and imported €80M — a €637M surplus in this category.
The EU's pharmaceutical products surplus with Japan has narrowed by about 59% over the past year, from €1.6B to €637M.
Japan supplied about 1% of the EU's extra-EU imports of pharmaceutical products in May 2026.
Updated monthly · latest data May 2026
— EU exports— EU imports137 months · latest 2026-05
EU exports
€717M
EU imports
€80M
Balance
€637M
Top sub-categories traded with Japan
EU exports →
- 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products€375M
- 3004Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)€283M
- 3003Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)€35M
- 3006Pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90€18M
- 3005Wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes€4.3M
← EU imports
- 3002Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products€38M
- 3004Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)€27M
- 3006Pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90€11M
- 3003Medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)€3.3M
- 3005Wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposes€1.4M
Monthly figures
| Month | EU exports | EU imports | Balance |
|---|---|---|---|
| May 2026 | €717M | €80M | €637M |
| April 2026 | €664M | €136M | €529M |
| March 2026 | €904M | €89M | €815M |
| February 2026 | €602M | €111M | €491M |
| January 2026 | €980M | €131M | €849M |
| December 2025 | €496M | €110M | €386M |
| November 2025 | €673M | €82M | €591M |
| October 2025 | €861M | €86M | €775M |
| September 2025 | €779M | €153M | €626M |
| August 2025 | €658M | €106M | €553M |
| July 2025 | €853M | €117M | €737M |
| June 2025 | €599M | €195M | €404M |
| May 2025 | €1.7B | €125M | €1.6B |
| April 2025 | €857M | €173M | €684M |
| March 2025 | €748M | €127M | €621M |
| February 2025 | €813M | €102M | €711M |
| January 2025 | €657M | €104M | €553M |
| December 2024 | €528M | €68M | €460M |
| November 2024 | €1.3B | €84M | €1.2B |
| October 2024 | €1.0B | €90M | €953M |
| September 2024 | €720M | €90M | €630M |
| August 2024 | €1.6B | €87M | €1.5B |
| July 2024 | €1.9B | €148M | €1.7B |
| June 2024 | €833M | €79M | €753M |
EU exports, imports and balance by month — extra-EU, EU27 reporter, latest 24 months.
Related trade lanes
Source: Eurostat — Comext DS-059341 · EU27 reporter · extra-EU trade · value in EUR. Figures are indicative and may be revised; verify against Eurostat before relying on them.